LWCFA
GEHC icon

Loring Wolcott & Coolidge Fiduciary Advisors’s GE HealthCare GEHC Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.5K Sell
1,523
-7
-0.5% -$460 ﹤0.01% 389
2026
Q1 		$112K Sell
1,530
-52
-3% -$4.1K ﹤0.01% 372
2025
Q4 		$127K Buy
1,582
+30
+2% +$2.34K ﹤0.01% 358
2025
Q3 		$120K Hold
1,552
– – ﹤0.01% 366
2025
Q2 		$115K Sell
1,552
-6
-0.4% -$418 ﹤0.01% 333
2025
Q1 		$101K Sell
1,558
-902
-37% -$77.5K ﹤0.01% 330
2024
Q4 		$219K Sell
2,460
-140
-5% -$11.9K ﹤0.01% 275
2024
Q3 		$231K Sell
2,600
-62
-2% -$5.2K ﹤0.01% 270
2024
Q2 		$220K Buy
2,662
+52
+2% +$4.24K ﹤0.01% 263
2024
Q1 		$220K Sell
2,610
-300
-10% -$25K ﹤0.01% 265
2023
Q4 		$213K Sell
2,910
-450
-13% -$31.5K ﹤0.01% 274
2023
Q3 		$233K Sell
3,360
-1,963
-37% -$143K ﹤0.01% 267
2023
Q2 		$432K Buy
+5,323
New +$425K ﹤0.01% 222

Other funds holding GEHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's GEHC Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors reduced its GE HealthCare (GEHC) stake by 0.46% in Q2 2026, selling an estimated $460 and leaving 1,523 shares worth $97.5K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $432K in Q2 2023. 702 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 1,523 shares of GE HealthCare worth $97.5K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 7 GE HealthCare shares in Q2 2026, an estimated $460.
  • GE HealthCare made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #389 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's GE HealthCare position peaked at $432K in Q2 2023.
  • 702 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.